- Home
- CLDI vs NAAS Comparison
CLDI vs NAAS Comparison
Compare CLDI & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- NAAS
- Stock Information
- Founded
- CLDI 2014
- NAAS 2019
- Country
- CLDI United States
- NAAS China
- Employees
- CLDI N/A
- NAAS N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- NAAS Other Specialty Stores
- Sector
- CLDI Health Care
- NAAS Consumer Discretionary
- Exchange
- CLDI Nasdaq
- NAAS Nasdaq
- Market Cap
- CLDI 8.7M
- NAAS 9.0M
- IPO Year
- CLDI N/A
- NAAS 2017
- Fundamental
- Price
- CLDI $1.49
- NAAS $3.52
- Analyst Decision
- CLDI
- NAAS
- Analyst Count
- CLDI 0
- NAAS 0
- Target Price
- CLDI N/A
- NAAS N/A
- AVG Volume (30 Days)
- CLDI 231.9K
- NAAS 14.5K
- Earning Date
- CLDI 11-07-2025
- NAAS 10-24-2025
- Dividend Yield
- CLDI N/A
- NAAS N/A
- EPS Growth
- CLDI N/A
- NAAS N/A
- EPS
- CLDI N/A
- NAAS N/A
- Revenue
- CLDI N/A
- NAAS $21,817,052.00
- Revenue This Year
- CLDI N/A
- NAAS $378.49
- Revenue Next Year
- CLDI N/A
- NAAS N/A
- P/E Ratio
- CLDI N/A
- NAAS N/A
- Revenue Growth
- CLDI N/A
- NAAS N/A
- 52 Week Low
- CLDI $1.10
- NAAS $1.96
- 52 Week High
- CLDI $46.68
- NAAS $55.84
- Technical
- Relative Strength Index (RSI)
- CLDI 47.51
- NAAS 51.48
- Support Level
- CLDI $1.10
- NAAS $3.43
- Resistance Level
- CLDI $1.56
- NAAS $3.78
- Average True Range (ATR)
- CLDI 0.14
- NAAS 0.26
- MACD
- CLDI 0.01
- NAAS 0.01
- Stochastic Oscillator
- CLDI 69.49
- NAAS 71.05
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.